Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B Operating Income

As of the most recent data (June 2026), BDXB shows a operating income of $2B. That compares with $2.5B in the prior-year period — down 19.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BDXB's operating income is now $2B (was $2.5B) — a 19.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is outperforming or lagging.

Tracking BDXB's operating income over time shows whether Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is scaling, shrinking, or reshaping that part of the business. The current reading is $2B That compares with $2.5B in the prior-year period — down 19.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $2B) with ownership activity and broader fundamentals.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's operating income is $2B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.